118 related articles for article (PubMed ID: 36593255)
1. AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer.
Fu Y; Cao T; Zou X; Ye Y; Liu Y; Peng Y; Deng T; Yin L; Li X
Oncogenesis; 2023 Jan; 12(1):1. PubMed ID: 36593255
[TBL] [Abstract][Full Text] [Related]
2. Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation.
Peng Y; Tang R; Ding L; Zheng R; Liu Y; Yin L; Fu Y; Deng T; Li X
Eur J Pharmacol; 2023 Mar; 942():175522. PubMed ID: 36681316
[TBL] [Abstract][Full Text] [Related]
3. M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability.
Ma H; Chen H; Guo X; Wang Z; Sowa ME; Zheng L; Hu S; Zeng P; Guo R; Diao J; Lan F; Harper JW; Shi YG; Xu Y; Shi Y
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4828-33. PubMed ID: 22411829
[TBL] [Abstract][Full Text] [Related]
4. PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability.
Peng Y; Liu Y; Zheng R; Ye Y; Fu Y; Yin L; Gao Y; Fu Y; Qi X; Deng T; Zhang S; Li X
Cell Death Discov; 2023 Oct; 9(1):367. PubMed ID: 37788997
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4‑2 CRPC cell line.
Zhao J; Li Q; Feng B; Wei D; Han Y; Li M; Wang Y; Luo Y; Jiang Y
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34698359
[TBL] [Abstract][Full Text] [Related]
6. PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells.
Yin L; Liu Y; Peng Y; Peng Y; Yu X; Gao Y; Yuan B; Zhu Q; Cao T; He L; Gong Z; Sun L; Fan X; Li X
J Exp Clin Cancer Res; 2018 Jul; 37(1):153. PubMed ID: 30012171
[TBL] [Abstract][Full Text] [Related]
7. Silencing UHRF1 enhances cell autophagy to prevent articular chondrocytes from apoptosis in osteoarthritis through PI3K/AKT/mTOR signaling pathway.
Shi X; Han L; Sun T; Zhang F; Ji S; Zhang M; Wang X; Yang W
Biochem Biophys Res Commun; 2020 Sep; 529(4):1018-1024. PubMed ID: 32819559
[TBL] [Abstract][Full Text] [Related]
8. UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications.
Gao Y; Liu Y; Liu Y; Peng Y; Yuan B; Fu Y; Qi X; Zhu Q; Cao T; Zhang S; Yin L; Li X
Cancer Lett; 2021 Nov; 520():172-183. PubMed ID: 34265399
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin E3 ligase UHRF1 regulates p53 ubiquitination and p53-dependent cell apoptosis in clear cell Renal Cell Carcinoma.
Ma J; Peng J; Mo R; Ma S; Wang J; Zang L; Li W; Fan J
Biochem Biophys Res Commun; 2015 Aug; 464(1):147-53. PubMed ID: 26102039
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of UHRF1 promoted the proliferation of vascular smooth cells via the regulation of Geminin protein levels.
Chen X; Zhou YL; Liang SY; Shi YC; Lin S; Shu MQ
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30710064
[TBL] [Abstract][Full Text] [Related]
11. Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway.
Liu Y; Liang G; Zhou T; Liu Z
Pathol Oncol Res; 2020 Apr; 26(2):1079-1088. PubMed ID: 31044388
[TBL] [Abstract][Full Text] [Related]
12. DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase.
Chen H; Ma H; Inuzuka H; Diao J; Lan F; Shi YG; Wei W; Shi Y
Mol Cell Biol; 2013 Mar; 33(6):1139-48. PubMed ID: 23297342
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness.
Yuan B; Liu Y; Yu X; Yin L; Peng Y; Gao Y; Zhu Q; Cao T; Yang Y; Fan X; Li X
Cell Death Dis; 2018 May; 9(5):562. PubMed ID: 29752436
[TBL] [Abstract][Full Text] [Related]
14. Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway.
Hui B; Pan S; Che S; Sun Y; Yan Y; Guo J; Gong T; Ren J; Zhang X
Cancer Manag Res; 2021; 13():4841-4852. PubMed ID: 34188537
[TBL] [Abstract][Full Text] [Related]
15. ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer.
Gao S; Ye H; Gerrin S; Wang H; Sharma A; Chen S; Patnaik A; Sowalsky AG; Voznesensky O; Han W; Yu Z; Mostaghel EA; Nelson PS; Taplin ME; Balk SP; Cai C
Clin Cancer Res; 2016 Jul; 22(14):3672-82. PubMed ID: 26936914
[TBL] [Abstract][Full Text] [Related]
16. Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling.
Huang SH; Tseng JC; Lin CY; Kuo YY; Wang BJ; Kao YH; Muller CJF; Joubert E; Chuu CP
Phytomedicine; 2019 Nov; 64():153068. PubMed ID: 31419729
[TBL] [Abstract][Full Text] [Related]
17. A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling.
Moll JM; Kumagai J; van Royen ME; Teubel WJ; van Soest RJ; French PJ; Homma Y; Jenster G; de Wit R; van Weerden WM
Prostate; 2019 Jun; 79(9):937-948. PubMed ID: 31017696
[TBL] [Abstract][Full Text] [Related]
18. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
De Marco C; Laudanna C; Rinaldo N; Oliveira DM; Ravo M; Weisz A; Ceccarelli M; Caira E; Rizzuto A; Zoppoli P; Malanga D; Viglietto G
PLoS One; 2017; 12(6):e0178865. PubMed ID: 28662101
[TBL] [Abstract][Full Text] [Related]
19. Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.
Moll JM; Hofland J; Teubel WJ; de Ridder CMA; Taylor AE; Graeser R; Arlt W; Jenster GW; van Weerden WM
Prostate; 2022 Apr; 82(5):505-516. PubMed ID: 35037287
[TBL] [Abstract][Full Text] [Related]
20. The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation.
Vaughan RM; Rothbart SB; Dickson BM
J Biol Chem; 2019 Oct; 294(43):15724-15732. PubMed ID: 31481468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
